Mole Removal: Recommended Procedures and Considerations
For suspicious moles or those requiring removal, complete excisional biopsy with 2-5 mm margins and a cuff of fat is the standard approach, while prophylactic removal of benign-appearing moles is not recommended. 1, 2
When to Remove a Mole
Urgent Referral Criteria
Refer immediately to a dermatologist or specialist when any of the following are present: 1
- New mole appearing after puberty that is changing in shape, color, or size 1
- Long-standing mole with changes in shape, color, or size 1
- Three or more colors present or loss of symmetry 1
- Symptoms including itching or bleeding 1
- New pigmented line in a nail, especially with associated nail damage 1
When NOT to Remove
- Prophylactic excision of benign-appearing pigmented lesions or small congenital nevi without suspicious features is futile and not recommended 1, 3
- Over-the-counter mole removal creams should never be used, as they preclude histopathologic evaluation and can cause scarring 4, 5
Proper Removal Technique
For Suspicious Lesions (Possible Melanoma)
Complete excisional biopsy is mandatory: 1, 2
- Photograph the lesion before removal 1
- Excise the entire lesion with 2 mm clinical margin of normal skin 1
- Include a cuff of subcutaneous fat to allow accurate Breslow thickness measurement 1
- Orient the excision axis to facilitate possible future wide excision (typically along the long axis on limbs) 1
Critical Technical Errors to Avoid
Never perform the following for suspicious lesions: 1, 2
- Shave biopsies - these lead to sampling error and make accurate pathological staging impossible 1, 2
- Punch biopsies - same limitations as shave biopsies 1
- Partial removal - creates pseudomelanoma appearance, causing diagnostic confusion and needless anxiety 1, 2
- Incisional biopsy in primary care - only acceptable by specialists for specific situations like facial lentigo maligna 1, 3
For Atypical (Dysplastic) Nevi
Management depends on degree of atypia: 2, 6
- Mild to moderate atypia with positive margins after biopsy: Observation is acceptable, as local recurrence rates are minimal (3.6% over 2 years) and melanoma transformation risk is very low 6
- Severe dysplasia or solitary atypical nevus: Conservative re-excision with 2-5 mm margins is preferred 2, 6
- Multiple atypical nevi: Removing all is neither necessary nor cost-effective 7
Special Anatomic Considerations
Facial lesions (lentigo maligna): 3
- Incisional biopsy is acceptable for diagnosis 3
- Standard treatment is excision with 0.5 cm margin for in situ disease 1, 3
- Alternative options for elderly patients or when excision is contraindicated: radiotherapy, CO2 laser, or cryotherapy 1, 3
Subungual lesions: 1
Margins for Confirmed Melanoma
If melanoma is confirmed on pathology, definitive excision margins depend on Breslow thickness: 1, 3
- <1 mm depth: 1 cm margin is safe 1, 3
- 1-2 mm depth: Minimum 1 cm margin, with 2 cm preferred where functionally and cosmetically sensible 1, 3
- 2-4 mm depth: 2 cm margins recommended 1, 3
High-Risk Patient Surveillance
Moderately Increased Risk (8-10x general population)
Includes patients with: 1
- Previous primary melanoma 1
- Large numbers of moles, some clinically atypical 1
- Organ transplant recipients 1
Management: Counsel about risk, teach monthly self-examination, but long-term follow-up is not usual 1
Greatly Increased Risk (>10x general population)
- Giant congenital pigmented nevi require long-term follow-up 1, 2
- Family history of 3+ melanomas or pancreatic cancer: Refer to clinical geneticist 1
Common Pitfalls
- Using destructive methods (laser, electrodesiccation, over-the-counter creams) prevents histopathologic evaluation and may mask malignant transformation 4
- Removing suspicious lesions in primary care - these should be referred to specialists for proper evaluation and removal 1
- Inadequate specimen depth - failing to include subcutaneous fat prevents accurate Breslow thickness determination 1
- Prophylactic removal of all atypical moles - this is neither clinically beneficial nor cost-effective 7, 8